Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor ...
2d
Antibody Discovery Market to Hit USD 35.35 Billion by 2035, Driven by AI and Technology Innovations
The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, ...
Standardized monitoring workflows and clearer reimbursement support are critical to improving community clinicians’ readiness ...
The ATS/ERS 2025 statement on interstitial pneumonia classification updates the 2013 statement, with insights on secondary ...
Rheumatoid arthritis (RA) is the leading indication, accounting for approximately 36% of the total market value, or USD 35.7 ...
Nasal vaccines offer convenience and another option for those wary of needles, but traditional vaccines are best for young ...
Doctors often say labs look “normal.” Dr. Mark Hyman explains why that doesn’t always reflect wellness, and what early ...
Immunocore is expanding its ImmTAX platform into autoimmune disease, outlining plans to start first‑in‑human trials of ...
Early ASH 2025 data suggest sonrotoclax is a promising therapy in MCL, supporting a broader shift toward chemo-free, combination-based strategies—particularly for patients with BTK ...
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...
According to DataM Intelligence, the global Inflammatory Diseases Biologics Market was valued at USD 99.06 billion in 2024 and is projected ...
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results